1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250...
-
Upload
janice-doyle -
Category
Documents
-
view
214 -
download
2
Transcript of 1 2 Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250...
1
2
Vitamin A deficiency can result in night blindness and weakened immunity. It affects over 250 million people each year.
I can’t see in dim light.
3
Our body can synthesize vitamin A from beta-carotene.
4
Scientists have successfully transferred the genes for producing beta-carotene from maize and bacteria to rice plants.
genes
5
The resultant Golden Rice can produce high levels of beta-carotene in its grains.
6
A Swiss scientist developed transgenic golden rice rich in iron and vitamin A, two major nutrient deficiencies in developing countries where the major staple food is rice. This involved genetically engineering 3 proteins and the vitamin precursor β-carotene from 4 different species.
7
What are the advantages of geneticengineering over traditional breeding in crop improvement
1
8
2.1 Biotechnology in medicine
• human insulin
Production of pharmaceutical products
• human growth hormone• vaccines• monoclonal antibodies (單克隆抗體 )
similar processes
9
1 Human growth hormone (HGH)• secreted from the pituitary gland
2.1 Biotechnology in medicine
• important in development of bones and muscles
• deficiency:
10
• HGH was extracted from the pituitary gland of dead people
2.1 Biotechnology in medicine
limited supply
1 Human growth hormone (HGH)
contaminated with pathogens
11
2.1 Biotechnology in medicine
1 Human growth hormone (HGH)• recombinant HGH
unlimited amount
pure
low cost
12
2.1 Biotechnology in medicine
1 Human growth hormone (HGH)• bacteria are commonly used
- provide plasmids that act as vectors
- serve as host cells
- can be transformed easily
- can grow rapidly
- can grow in inexpensive culture media
- relatively stable culture
13
2 Vaccines• antigenic proteins can be produced by
recombinant DNA technology
2.1 Biotechnology in medicine
e.g. vaccines against hepatitis B
14
Prepare a recombinant plasmid
2.1 Biotechnology in medicine
2 Vaccines
gene for viral surface protein
plasmid
15
Introduce the recombinant plasmid into a yeast cell
2.1 Biotechnology in medicine
2 Vaccines
yeast cell
16
Culture GM yeast on a large scale
2.1 Biotechnology in medicine
2 Vaccines
17
According to the genetic information of the viral gene, the GM yeast produces the viral surface protein
2.1 Biotechnology in medicine
2 Vaccines
18
The viral surface protein is collected and purified for use
2.1 Biotechnology in medicine
2 Vaccines
19
2 Vaccines• traditional hepatitis B vaccines contain
the whole viruses
2.1 Biotechnology in medicine
viruses may become active and infectious
• recombinant hepatitis B vaccines contain only a viral surface protein
safer to use
20
Principle of EdibleEdible vaccine
21
3 Monoclonal antibodies• antibodies produced by the cell clones
derived from a single parent B cell
2.1 Biotechnology in medicine
• highly specific
22
"magic bullet" monoclonal antibody1. myeloma cells –
keeing dividing--immortal
2. fuse with healthy antibody-producing B-cells
3. Hybridomas produced
4. select hybridomas cells with specific antibodies
5. Grow in culture
6. Harvest monoclonal antibodies
23
3 Monoclonal antibodiesi) For diagnosis of diseases
2.1 Biotechnology in medicine
• recognize the surface proteins of cancer cells in tissue samples
24
3 Monoclonal antibodiesii) For developing sensitive tests
2.1 Biotechnology in medicine
• home pregnancy tests• bind to human chorionic gonadotrophin
(HCG) in urine
25
Application of monoclonal antibodies:
Pregnancy testing kit
26
3 Monoclonal antibodiesiii) For isolating and purifying
important biological molecules
2.1 Biotechnology in medicine
• specific to the molecule of interest
27
3 Monoclonal antibodies• Drawback of
monoclonal antibodies produced using B cells from mice
2.1 Biotechnology in medicine
could stimulate an immune response in humans Results in their rapid removal from the blood, inflammatory effects, and the production of human anti-mouse antibodies
28
In vitro / Recombinant Monoclonal antibodies:
2.1 Biotechnology in medicine
less likely to be destroyed in the human body
a human antibody with a small part of a mouse monoclonal antibody
Made by merging mouse DNA encoding the binding portion of a monoclonal antibody with human antibody-producing DNA in living cells, and the expression of this hybrid DNA through cell culture yielded partially mouse, partially human monoclonal antibody.
29
3 Monoclonal antibodies• recombinant monoclonal antibodies
2.1 Biotechnology in medicine
• used in the treatment of some forms of cancer- linked with a toxic drug
or a radioactive substance –magic bulletmagic bullet
30
Gene therapy• to treat a disease by supplementing the
defective gene with a normal gene
2.1 Biotechnology in medicine
• vectors for transferring a normal gene into a target celle.g. harmless viruses
31
Diagram of the human chromosome set, showing the location of some genes whose mutant forms can cause hereditary diseases. Conditions that can be diagnosed using DNA analysis are indicated by a red dot.
32
Gene therapy• ex vivo (先體外後體內 ) gene therapy:
2.1 Biotechnology in medicine
cells are genetically modified outside the body and then put back into the patient
33
Gene therapy with a retrovirus
34
Gene therapy• in vivo (體內 ) gene
therapy:
2.1 Biotechnology in medicine
cells are genetically modified inside the body
vectors with normal genes
direct transfer of normal genes into cells
35
36
Cystic fibrosis (CF), the most common lethal, single-gene disorder affecting Northern Europeans and North Americans, is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
37
Gene therapy• germ line gene therapy (種系基因治療 ) :
2.1 Biotechnology in medicine
corrects the genetic material of gametes or zygotes
• genetic correction is inheritable• done on animals only
38
Gene therapy• somatic cell gene therapy (體細胞基因治療 ) :
2.1 Biotechnology in medicine
corrects the genetic material of somatic cells
• genetic correction is not inheritable• all human trials are of this type
39
Gene therapy
• treat genetic diseases, cancer and infectious diseases
2.1 Biotechnology in medicine
• as a preventive measure against diseases• correct a disease before it develops and help remove all the defective genes in the human population
Potential benefitsPotential benefits
40
Gene therapy
• viral vectors cause diseases
2.1 Biotechnology in medicine
• viral vectors cause severe immune reactions
• insertion of new genes affects the expression of existing genes
Potential hazardsPotential hazards
41
Gene therapy
• new genes wrongly transported into non-target cells, produce too much of the missing protein or produce the protein at the wrong time
2.1 Biotechnology in medicine
Potential hazardsPotential hazards
42
Risks involved in gene therapy• in an attempt experiment to treat
Ornithine transcarbamylase deficiency by gene therapy, a patient died in 1999.
• The patient was injected with adenoviruses carrying a corrected gene in the hope that it would manufacture the needed enzyme.
• He died four days later, apparently having suffered a massive immune response triggered by the use of the viral vector used to transport the gene into his cells.
43
Risks involved in gene therapy• in an attempt experiment to treat
Ornithine transcarbamylase deficiency by gene therapy, a patient died in 1999.
• The patient was injected with adenoviruses carrying a corrected gene in the hope that it would manufacture the needed enzyme.
• He died four days later, apparently having suffered a massive immune response triggered by the use of the viral vector used to transport the gene into his cells.
44
.
• tampering with human genes might lead to the practice of eugenics, a deliberate effort to control the genetic makeup of human populations.
• The most difficult ethical question is whether we should treat human germ-line cells to correct the defect in future generations.
• we will have to face the question of whether it is advisable, under any circumstances, to alter the genomes of human germ lines or embryos. Should we interfere with human evolution in this way?
Gene therapy poses many ethical and social questions
Gene therapy poses many ethical and social questions
45
Stem cell therapy2.1 Biotechnology in medicine
• unspecialized cells
• unlimited mitotic cell division
• can differentiate into different kinds of cells
• Embryonic stem cells /Adult stem cells
• Differs in their “potency”
• unspecialized cells
• unlimited mitotic cell division
• can differentiate into different kinds of cells
• Embryonic stem cells /Adult stem cells
• Differs in their “potency”
46
totipotent, pluripotent, multipotent?
47
totipotent, pluripotent, multipotent?
• TotipotentTotipotent cells can form all the cell types in a body, plus the extraembryonic, or placental, cells. Embryonic cells within the first couple of cell divisions (8-cell stage) after fertilization are the only cells that are totipotent.
• PluripotentPluripotent cells can give rise to all of the cell types that make up the body. e.g. embryonic stem cells (16-cell stage).
• MultipotentMultipotent cells can develop into more than one cell type, but are more limited than pluripotent cells; adult stem cells and cord blood stem cells, peripheral blood stem cells are considered multipotent.
48
Stem cell therapy2.1 Biotechnology in medicine
embryonic stem cells
• from blastocysts
• can differentiate into almost any cell types
(Pluripotent)
embryonic stem cells
• from blastocysts
• can differentiate into almost any cell types
(Pluripotent)
49
After fertilization, the zygote undergoes cleavage:the first few mitotic divisions multiply the total number of cells without increasing total mass.The ball of cells that implants in the uterus is a blastocyst, and contains the inner cell mass, where embryonic stem cells can be harvested.
50
Stem cell therapy2.1 Biotechnology in medicine
adult stem cells
• from childhood or adult tissues like bone marrow, blood, skeletal muscles
• can only differentiate into a limited range of cell types “Multipotent” or unipotent
adult stem cells
• from childhood or adult tissues like bone marrow, blood, skeletal muscles
• can only differentiate into a limited range of cell types “Multipotent” or unipotent
51
Stem cell therapy2.1 Biotechnology in medicine
• stem cells may be used to replace damaged or abnormal cells in the treatment of diseasese.g. blood stem cells in bone marrow and in
peripheral blood, cord blood (臍帶血 ) containing blood stem cells are used in the treatment of blood diseases (multipotent)
52
Stem cell therapy2.1 Biotechnology in medicine
e.g. human embryonic stem cells
human blastocyst
isolate embryonic stem cells
cultured embryonic stem cells
53
Stem cell therapy2.1 Biotechnology in medicine
e.g. human embryonic stem cells
induce the cells to differentiate into specific cell types
insulin-producing cells• for treating type 1 diabetes
54
Stem cell therapy2.1 Biotechnology in medicine
e.g. human embryonic stem cells
induce the cells to differentiate into specific cell types
cardiac muscle cells• for treating heart disease
55
Stem cell therapy2.1 Biotechnology in medicine
e.g. human embryonic stem cells
induce the cells to differentiate into specific cell types
neurones• for treating spinal cord injuries,
Parkinson’s disease
56
• Since the regrown cells originate from the patient, there should be no immune rejection of the transplanted tissue.
Stem cell therapy / stem cell cloning
57
Stem cell therapy2.1 Biotechnology in medicine
• isolation of embryonic stem cells involves destruction of human embryos
controversial• adult stem cells occur in low number,
are difficult to isolate and can only differentiate into a limited range of cell types
58
Stem cell therapy2.1 Biotechnology in medicine
• human skin cells were successfully re-programmed to become unspecialized cells in 2007 – IPS cells
Nobel Prize in physiology or
medicine (2012)
59
Stem cell therapy2.1 Biotechnology in medicine
may act as a limitless source of immune-compatible cells for transplantation
• human skin cells were successfully re-programmed to become unspecialized
cells in 2007 –IPS cells
60
Sources of stem cells (1) human embryos
61
Sources of stem cells (2) IPS – induced pluripotent stem cells
62
Sources of stem cells (2) IPS – induced pluripotent stem cells
63
64
Applications of IPS cells
65
Stem cell therapy2.1 Biotechnology in medicine
• questions to be answered
How can we induce embryonic stem cells to differentiate into
each of the desired cell types?
66
Stem cell therapy2.1 Biotechnology in medicine
• questions to be answered
Are re-programmed cells safe to use in therapy?
How long can the transplanted cells last in the body?
67
1 Some examples of pharmaceutical products using biotechnology include human insulin, human growth hormone, and vaccines
.monoclonal antibodies
2.1 Biotechnology in medicine
68
2 Monoclonal antibodies are antibodies produced by theclones
derived from a single parent B cell.
2.1 Biotechnology in medicine
cell
69
3 is to treat a disease by supplementing the defective gene with a normal gene.
2.1 Biotechnology in medicine
Gene therapy
70
4
2.1 Biotechnology in medicine
gene therapy
gene therapy
Affects gametes and zygotes
Affects somatic cells
Genetic correction is inheritable
Genetic correction is not inheritable
Germ line Somatic cell
71
a It may treat genetic diseases, cancer and infectious diseases.
5 Potential benefits of gene therapy:
preventive
2.1 Biotechnology in medicine
b It may be used as a measure against diseases.
72
c It may correct a disease before the disease develops in the individuals and help remove all the in the human population.
5 Potential benefits of gene therapy:
defective genes
2.1 Biotechnology in medicine
73
a Viral vectors may gain the ability to cause diseases during modification.
6 Potential hazards of gene therapy:
immune reactions
2.1 Biotechnology in medicine
b Viral vectors may cause severe.
74
c The insertion of new genes may affect the of existing genes.
6 Potential hazards of gene therapy:
2.1 Biotechnology in medicine
expression
75
d The new genes may be wrongly transported into cells. They may also produce too much of the missing protein or produce the protein at the wrong time. This results in other health problems.
6 Potential hazards of gene therapy:
2.1 Biotechnology in medicine
non-target
76
e The patient is repeatedly exposed to possible hazards when
6 Potential hazards of gene therapy:
2.1 Biotechnology in medicine
repeated gene therapy is required.
77
7 Stem cells may be used in the treatment of type diabetes, heart disease, muscular dystrophy,
2.1 Biotechnology in medicine
1
spinal cord injuries, Parkinson’s disease, etc.
78
2.2 Biotechnology in agriculture
• organisms whose genetic material has been altered through genetic engineering
What are transgenic organisms?
Golden Rice
79
• transgenic organisms are useful in scientific research
for the study of gene functions
2.2 Biotechnology in agriculture
as disease models
for toxicity tests for new products
80
Transgenic plants in agriculture and the food industry• many transgenic plants are major crops
2.2 Biotechnology in agriculture
soya bean (52%)
maize (31%)
cotton (12%)
canola (5%)
81
Transgenic plants in agriculture and the food industry
• introduce genes for improving the yields or nutritional value of crops
2.2 Biotechnology in agriculture
• many transgenic plants are major crops
for food use and as parents in traditional breeding
82
2.2 Biotechnology in agriculture
1 Herbicide resistant soya beans and maize
• weeds can be killed by herbicide
83
2.2 Biotechnology in agriculture
2 Pest resistant maize and cotton
• toxin is pest-specific• reduces the use of chemical pesticides
84
2.2 Biotechnology in agriculture
3 Disease resistant papayas
• prevents crops from being damaged by diseases
• reduces the use of chemical pesticides
viral resistant non-transgenic
85
• crops can be grown in winter, dry climates and on saline lands
2.2 Biotechnology in agriculture
4 Rice, wheat and tomatoes tolerant to cold, drought or high salinity of soil
86
2.2 Biotechnology in agriculture
5 Tomatoes with a longer shelf life
• reduces the loss of fruits• fruits of better quality
non-transgenic
transgenic
87
2.2 Biotechnology in agriculture
6 Soya beans, canola and rice with improved nutritional value
• higher levels of ‘good’ lipids help prevent heart disease
88
2.2 Biotechnology in agriculture
• higher levels of beta-carotene, vitamin E, iron, zinc or lysine prevent dietary deficiencies
6 Soya beans, canola and rice with improved nutritional value Animation
89
Transgenic animals in agriculture and the food industry• introduce genes for improving the
productivity and quality of farm animals
2.2 Biotechnology in agriculture
90
2.2 Biotechnology in agriculture
1 Fast-growing salmon
• decreases overfishing of wild salmon
non-transgenic transgenic
91
2.2 Biotechnology in agriculture
2 Cold resistant salmon• expands the area for fish farming
3 Transgenic pigs that produce more lean tissue and less fat
• improves human health
92
2.2 Biotechnology in agriculture
4 Transgenic goats that produce milk with improved composition and production
• produces lactose-free milk suitable for people who cannot tolerate lactose
93
2.2 Biotechnology in agriculture
4 Transgenic goats that produce milk with improved composition and production
• produces milk with a lower level of ‘bad’ lipids which is healthier for the heart
94
2.2 Biotechnology in agriculture
4 Transgenic goats that produce milk with improved composition and production
• increases milk production
95
2.2 Biotechnology in agriculture
5 Transgenic sheep that produce more wool of better quality
• improves the quality of wool• increases wool production
96
2.2 Biotechnology in agriculture
6 Transgenic pigs that produce 60% less phosphorus in their manure
• reduces pollution caused by manure
97
1 are organisms whose genetic material has been altered through genetic engineering.
Transgenic organisms
2.2 Biotechnology in agriculture
98
a They are used for the study of
2 Uses of transgenic plants and animals in scientific research:
gene
b They act as models.
2.2 Biotechnology in agriculture
functions.
disease
c They are used for tests for new products.
toxicity
99
• resistance to herbicides,
3 Examples of desirable characteristics built into transgenic plants:
diseases
2.2 Biotechnology in agriculture
andcold drought
pests
• tolerance to , or high salinity of soil
100
• delayed or
3 Examples of desirable characteristics built into transgenic plants:
2.2 Biotechnology in agriculture
nutritional value
softening• improved
ripening
101
• improved meat or milk
• resistance
• faster growth
4 Examples of desirable characteristics built into transgenic animals:
cold
2.2 Biotechnology in agriculture
andcomposition production
102
• manure with low levels of
• improved wool quality and production
4 Examples of desirable characteristics built into transgenic animals:
phosphorus
2.2 Biotechnology in agriculture
103
a Transgenic plants and animals with improved productivity and quality are produced. They may provide a more reliable
5 Uses of transgenic plants and animals in agriculture:
2.2 Biotechnology in agriculture
foodsupply for all people.
104
b They can be used as in traditional breeding.
5 Uses of transgenic plants and animals in agriculture:
2.2 Biotechnology in agriculture
parents
105
c They can help protect the environment by reducing the use of chemical or producing less polluting .
5 Uses of transgenic plants and animals in agriculture:
2.2 Biotechnology in agriculture
pesticidesmanure
106
In addition to beta-carotene, whatother useful products can be produced from genetic engineering?
1
Human insulin, human growth factor, vaccines and monoclonal antibodies can be produced from genetic engineering.
107
What are the advantages of geneticengineering over traditional breeding in crop improvement?
2
Genetic engineering provides a quicker and more precise method to modify the genetic make-up and hence the characteristics of crops.
108
What are the advantages of geneticengineering over traditional breeding in crop improvement?
2
It also allows the transfer of new characteristics from completely non-related species.
109
applications in medicine include
Biotechnology
production of pharmaceutical
products
gene therapy
stem cell therapy
110
examples
production of pharmaceutical products
human insulin
human growth hormone
vaccinesmonoclonal antibodies
111
gene therapy
divided into
germ line gene therapy
somatic cell gene therapy
112
used to produce Biotechnology
productivity quality
transgenic plants and animals
used in agriculture to improve